Trial Profile
A Phase 2 Open Label Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2020
Price :
$35
*
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Skin disorders
- Focus Therapeutic Use
- Sponsors Aclaris Therapeutics
- 02 May 2019 Status changed from active, no longer recruiting to completed.
- 02 Oct 2018 Planned End Date changed from 1 Sep 2018 to 1 Dec 2018.
- 02 Oct 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Dec 2018.